Fundraising Fox

Sue Xu

Investor

Managing Partner at Amino Capital

Palo Alto, California

Writes $10M checks Β· typically $500K

About

Managing Partner at Amino Capital since 2012, focused on seed and Series A investments across generative AI, consumer, SaaS, and frontier tech, with a thesis centered on data moats and network effects. A former Stanford medical researcher and repeat lab-spinout founder (CandyHouse, CyteSi, GlycoMira), she holds three patents and has backed numerous unicorns.

ContactΒ· self-published, not guessed

Invests in

AI & Machine LearningBiotechConsumerCrypto & Web3Deep TechEnterprise SoftwareFintechSaaSSector Agnostic

Experience

  1. Amino CapitalManaging Partnercurrent2012 β€” presentPalo Alto
  2. ChipAgentsInvestorcurrent2024 β€” presentSan Francisco Bay Area
  3. AvocaInvestorcurrent2023 β€” presentNew York, United States
  4. JuiceboxInvestorcurrent2022 β€” presentSan Francisco Bay Area
  5. TuringInvestorcurrent2020 β€” presentPalo Alto, California, United States
  6. d-MatrixInvestorcurrent2020 β€” presentUnited States
  7. ReplitInvestorcurrent2018 β€” present
  8. RipplingInvestorcurrent2017 β€” present
  9. GRAIL, Inc.Investorcurrent2017 β€” present
  10. InstaworkInvestorcurrent2015 β€” presentSan Francisco Bay Area
  11. Weee!Investorcurrent2015 β€” present
  12. DFINITYInvestorcurrent2016 β€” presentPalo Alto, California, United States
  13. WebflowInvestorcurrent2013 β€” presentSan Francisco, California, United States
  14. ChimeInvestorcurrent2013 β€” presentSan Francisco, California, United States
  15. Stanford Angels & EntrepreneursAngel Investorcurrent2013 β€” presentStanford, California, United States
  16. CANDY HOUSE, Inc.Chief Executive Officer2014 β€” 2016Palo Alto, California, United States
  17. Stanford University Graduate School of BusinessHealthcare Summit2011

Skills & more

Strategy67Engineering1Integrated Marketing1Engineering PhysicsMethods EngineeringExecutive Management1Board of Directors1Pharmaceutical Industry66Business Strategy99Lifesciences38Biotechnology85HPLC15
+6 moreMedical DevicesStart-upsCross-functional Team LeadershipCompetitive AnalysisProduct DevelopmentTechnology Transfer

From Sue's professional profile.

Investments

Per the firm's website.

Colleagues at Amino Capital

Frequently asked questions

Who is Sue Xu?
Managing Partner at Amino Capital since 2012, focused on seed and Series A investments across generative AI, consumer, SaaS, and frontier tech, with a thesis centered on data moats and network effects. A former Stanford medical researcher and repeat lab-spinout founder (CandyHouse, CyteSi, GlycoMira), she holds three patents and has backed numerous unicorns.
Where does Sue Xu work?
Sue Xu is Managing Partner at Amino Capital.
What does Sue Xu invest in?
Sue Xu invests in AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Deep Tech, Enterprise Software, Fintech, SaaS, Sector Agnostic.
What check size does Sue Xu write?
Sue Xu typically writes checks of $10M.
What companies has Sue Xu invested in?
Investments tracked here include Chime, Dfinity, GetAccept, GRAIL, Guesty, Instawork, Karbon Card, Oasis Labs, Omisego, Replit, Rippling, StarRocks, and 7 more.
Where did Sue Xu go to school?
Sue Xu studied at Stanford University; Stanford University Graduate School of Business (non-degree interdisciplinary courses); Stanford University School of Medicine (Dermatology).

Same school

Shared employers